Use of MonitorMe in COPD
Launched by UNIVERSITY OF LINCOLN · Sep 26, 2019
Trial Information
Current as of September 03, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients
- • Adults diagnosed with any severity of COPD (according to British Thoracic Society criteria, i.e. \>10 pack year smoking history and post bronchodilator spirometry FEV1/FVC ratio \<0.70 and FEV\<80%)
- • Listed on referral lists or COPD registers within Lincolnshire Community Health Services NHS Trust or NHS South West Lincolnshire CCG
- • Health care professionals
- • Involved in implementing the device within Lincolnshire Community Health Services NHS Trust or NHS South West Lincolnshire CCG
- • Provide informed consent to participate in an interview
- Exclusion Criteria:
- • Patients
- • Inability or unwillingness to sign informed consent
- • No active telephone line in home
- • COPD exacerbation within the previous 6 weeks.
- • Mental health, cognitive or neurological conditions that would make study participation inappropriate
- • Life expectancy \< 6 months
- • Implanted pacemaker
- • Hearing or visual ailments that would preclude the use of the MonitorMe device
- • Inability to use both hands (i.e. hold handset in one hand and use keypad with the other at same time)
- • Inability to understand verbal English
- • Health care professionals
- • Not involved in implementing the device within Lincolnshire Community Health Services NHS Trust or NHS South West Lincolnshire CCG
- • Unable/unwilling informed consent to participate in an interview
About University Of Lincoln
The University of Lincoln is a leading academic institution dedicated to advancing knowledge and research across various disciplines, including health and clinical sciences. With a commitment to innovation and excellence, the university actively engages in clinical trials aimed at improving patient outcomes and contributing to the scientific community. Leveraging state-of-the-art facilities and a collaborative approach, the University of Lincoln fosters partnerships with healthcare providers and industry stakeholders to ensure rigorous study designs and ethical practices in clinical research. Through its dedication to education, research, and community engagement, the university plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lincoln, , United Kingdom
Lincoln, , United Kingdom
Patients applied
Trial Officials
Aloysius N Siriwardena, MBBS, PhD
Principal Investigator
University of Lincoln
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials